Takeda Pharmaceutical Debt-to-Assets Ratio Growth & History (TAK)

Takeda Pharmaceutical's debt-to-assets ratio was 0.31 for fiscal 2026.

View full Takeda Pharmaceutical company overview

Takeda Pharmaceutical annual debt-to-assets ratio history

Takeda Pharmaceutical annual debt-to-assets ratio

Fiscal yearPeriod endedDebt-to-assets ratioChangeGrowth
20262026-03-310.31−0.04−11.88%
20252025-03-310.36−0.00−1.24%
20242024-03-310.360.01+3.82%
20232023-03-310.35−0.02−4.58%
20222022-03-310.37−0.03−7.06%
20212021-03-310.39−0.03−7.81%
20202020-03-310.430.01+2.19%
20192019-03-310.420.18+73.71%
20182018-03-310.24

Takeda Pharmaceutical debt-to-assets ratio trends

Over the last five fiscal years, Takeda Pharmaceutical's debt-to-assets ratio decreased from 0.39 to 0.31, a change of −0.08. The latest reported quarter, Q1 2027, shows 0.32.

About the metric

What the debt-to-assets ratio means

The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.

Calculation and source

How debt-to-assets is calculated

TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Takeda Pharmaceutical source filings ↗

Community posts

It’s quiet here.

No posts about TAK yet. Start the conversation.

Write the first post